This compound specifically targeted c-Myc mRNA, downregulated β-TrCP1 mRNA, reduced NF-κB activity, and inhibited the proliferation and protein synthesis of IGF2BP1-positive tumor cells (Mahapatra et al. 2017). The gene discussed is IGF2BP1; the disease is neoplasm.